Abstract
Background
Snakebite in India results in over 58,000 fatalities and a vast number of morbidities annually. The majority of these clinically severe envenomings are attributed to Russell’s viper (Daboia russelii), which has a near pan-India distribution. Unfortunately, despite its medical significance, the influence of biogeography on the composition and potency of venom from disparate D. russelii populations, and the repercussions of venom variation on the neutralisation efficacy of marketed Indian antivenoms, remain elusive.
Methods
Here, we employ an integrative approach comprising proteomic characterisation, biochemical analyses, pharmacological assessment, and venom toxicity profiling to elucidate the influence of varying ecology and environment on the pan-Indian populations of D. russelii. We then conducted in vitro venom recognition experiments and in vivo neutralisation assays to evaluate the efficacy of the commercial Indian antivenoms against the geographically disparate D. russelii populations.
Findings
We reveal significant intraspecific variation in the composition, biochemical and pharmacological activities and potencies of D. russelii venoms sourced from five distinct biogeographic zones across India. Contrary to our understanding of the consequences of venom variation on the effectiveness of snakebite therapy, commercial antivenom exhibited surprisingly similar neutralisation potencies against the majority of the investigated populations, with the exception of low preclinical efficacy against the semi-arid population from northern India. However, the ability of Indian antivenoms to counter the severe morbid effects of Daboia envenoming remains to be evaluated.
Conclusion
The concerning lack of antivenom efficacy against the north Indian population of D. russelii, as well as against two other ‘big four’ snake species in nearby locations, underscores the pressing need to develop pan-India effective antivenoms with improved efficacy in high snakebite burden locales.
Funder
Department for International Development, UK Government
Department of Biotechnology, India
Department of Science and Technology, India
Wellcome Trust and Royal Society
USV Private Limited
Publisher
Public Library of Science (PLoS)
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health
Reference80 articles.
1. World Health Organization (WHO). Snakebite envenoming: WHO Press; 2019 [https://www.who.int/news-room/fact-sheets/detail/snakebite-envenoming].
2. Trends in snakebite deaths in India from 2000 to 2019 in a nationally representative mortality study;W Suraweera;Elife,2020
3. Coevolution of venom function and venom resistance in a rattlesnake predator and its squirrel prey;ML Holding;Proc Biol Sci,2016
4. Diet and snake venom evolution;JC Daltry;Nature,1996
5. Causes and Consequences of Snake Venom Variation;NR Casewell;Trends in Pharmacological Sciences,2020
Cited by
49 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献